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HNR 499 Independent Study
The Current State of ASD Research

Abstract:
The rising rates of autism diagnosis among children is becoming a topic of growing
interest among many arms of the research community. The most recent CDC data and statistics
suggests that the prevalence of autism in the US is about 11.3 per 1000 children; this equates to
about 1 in every 88 births (CDC, 2012). The trending increase in prevalence has increased the
need for autism research greatly. So much is unknown about the nature of Autism Spectrum
Disorders (ASD) that there is a seemingly endless range of subject matter for pertinent
research. There is currently such a surge of autism related research being published that it is
often difficult to discern what are the most significant discoveries. Investigators from many
disciplines are seeking answers to questions including; possible treatments, the accuracy of
current diagnostic criteria, pathology, epidemiology, economic impact, and risk factors for the
disorder. This paper will review my independent study on the current state of research in ASD,
media controversy surrounding autism, as well as explore future possibilities and
advancements.
Pathophysiology of Autism Spectrum Disorder
Autism is not a simple diagnosis. There is no straightforward and conclusive medical
test that can be done to identify the condition, however, the American Psychiatric Association's
Diagnostic and Statistical Manual-IV, Text Revision (DSM-IV-TR) lays out a series of criteria
for diagnosis. These criteria include abnormal social interactions, developmental delays,
stereotyped behavior, and issues with language, among other signs (First, 2002). The issue
with this method of diagnosis is that it is subjective, and diagnostic decisions could differ
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depending on the physician. This difficulty in diagnosis is compounded by the nature of autism
being not a singular condition, but a spectrum of disorders ranging from mildly impaired social
skills to the much more severe Childhood Disintegrative Disorder (CDD). There are currently
5 disorders classified under the umbrella of ASD. They are Autistic Disorder (AD), Rett’s
syndrome, Asperger syndrome, CDD, and Pervasive Developmental Disorder Not Otherwise
Specified (PDD-NOS) (DSM IV-TR).
As more information about these conditions are elucidated, even the current
classification scheme is in flux. In May 2013, the new APA DSM-5 is scheduled for release.
The proposed changes for the classification of the different ASD conditions as well as
diagnostic criteria are quite substantial. For example, some experts are seeking to merge
Asperger syndrome with Autistic disorder due to their similarity in long term prognosis and to
reduce the possibility of misdiagnosis (Mondre, 2011). However, this idea is opposed by
others since it may hinder the possibility of specialized treatment for each condition
independently. The proposed change to the DSM states, “different research groups often uses
different criteria, and quality of early language milestone information is variable” (Klin, &
Volkmar, 2005). Rett’s syndrome is also slated to be removed from the ASD umbrella since
it’s cause has been identified as purely genetic and it is distinct enough in its pathophysiology
to be placed in a separate category. Another significant change proposed in the DSM-5 is the
addition of categories of severity. These levels range from level 1, “requiring support”; to level
3, “requiring very substantial support” (APA, 2011). These classifications of severity are
designed to apply to all of the conditions included in the spectrum, and will make diagnosis
better suited to match treatment. It is more efficient for treatment and therapy to be based on
severity, and the APA expects this to streamline treatment options. However, the new, more
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strict criteria proposed for the DSM-5 could potentially exclude many individuals currently
classified as autistic by the DSM-IV-TR. The implications of this could become a substantial
issue for families receiving money from governmental aid programs.
Many tools have been developed to help ensure proper diagnosis, but misdiagnosis
remains an issue. An important step in diagnosis is distinguishing essential from complex
autism. Complex autism is defined as autism compounded with physical malformations,
suggesting a genetic link. This difference helps group patients not only for treatment, but the
division into distinct subgroups helps “increase the power of research analysis” (Science
Letter, 2005). As more subgroups are identified and characterized, a clearer picture of autism
will develop, as well as more specific research.
Comorbidities and Risk Factors
In order to discover the root cause of ASD, much research is directed towards studying
the many comorbidities associated with ASD.These studies are useful because comorbidities
with known mechanisms of pathogenesis may elucidate relationships with the mechanism of
autism and other neurodevelopmental disorders, as well as identifying risk factors linked to the
disease. Furthermore, it is important to distinguish symptoms of comorbidities from symptoms
of ASD, since methods of treatment may differ. These associated conditions include premature
birth (Gardener, 2011), congenital birth defects (Hultman, 2002), issues with motor skills
(Matson, 2011), a wide variety of neurological defects, seizures, chromosomal abnormalities
such as fragile-x syndrome and trisomy 21 (Morgan, 2003), and obesity. Investigations are
designed with statistical analysis to determine the relationship between these common
comorbid factors and ASD. The correlation with childhood obesity is especially intriguing,
since it is also a growing issue amongst children in America. A U.S. study found that 30.4% of
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autistic children are overweight, compared to 23.6% of the total population (Curtin, 2005).
Obesity could be secondary to autism, that is, children with ASD may have a tendency to eat
more or less healthy diets, or, it could be due to a physiological relationship, such as a
hormone imbalance. Relationships with related conditions such as obesity are significant
targets for future research. The use of advanced brain imaging techniques such as fMRI has
identified a relationship between ASD and schizophrenia. Researchers found that lower
volumes of grey matter in specific brain regions such as the striatum and amygdala were
common between schizophrenic and ASD patients (Cheung, 2010) (See Figure 1). Noticing
such structural relationships and deviations could lead to more accurate diagnosis based on
anatomical or histological abnormalities. Further research may prove fruitful if the disease
mechanisms for the two pathologically unique conditions are related. Although many papers
have been published on the subject of ASD comorbidities, there has not been much progress in
identifying any distinct cause. One study states, “A number of prenatal, perinatal, and
physical/motor factors appear to be associated with autism. At this point, whether these
disorders have common neurodevelopmental pathways, or are to some extent causative for
autism, are unknown” (Matson, 2011).
Along with identifying comorbidities, discovering and characterizing risk factors is also
an important step in finding the cause of neurodevelopmental disorders like ASD. Research has
identified a wide range of risk factors with varying degrees of significance. Many of the risk
factors have to do with conditions during pregnancy and embryonic development. A Swedish
case-control study on the perinatal risk factors for infantile autism found statistically
significant associations with smoking during pregnancy, delivery by cesarean, low-birth
weight, a low five minute Apgar score, and presence of congenital malformations (Hultman,
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2002). The study concluded that intrauterine conditions are important to the pathogenesis of
autism, and should be investigated further. Other risk factors associated with the mother’s
health during pregnancy have also been identified. A recent california study has identified a
correlation between obesity of the mother and higher rates of autism. Obese women were found
to be about 67% more likely than normal-weight mothers to have autistic children (Tanner,
2012). This provides evidence to support theories of pathogenesis involving prenatal
conditions. However, it is important to note that no study to date has found one distinct risk
factor strongly linked to autism. It is likely that, “exposure to a broad class of conditions
reflecting general compromises to perinatal and neonatal health may increase the risk”.
(Gardener, 2011).

Figure 1:”Distinct and overlapping regions of grey matter deficits found in ASD and
Schizophrenia”. (Cheung, 2010)
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Genetics and Neuroinformatics:
Gender association is a heavily researched topic in ASD, and for good reason. The
prevalence of autism in males is significantly higher than that of females. CDC data shows that
across all racial and socioeconomic groups, boys are between 4 and 5 times more likely than
girls to have autism. This is a compelling statistic, driving the focus of much research. The
reason for this link most likely lies in genetics, and research has suggested such. One such
gene under investigation is CACNA1G, which is located in chromosome 17. A mutation in this
calcium channel gene is much more common amongst males, and inheriting the mutation
increases the risk of developing autism (Genomics and Genetics, 2009). Further investigation
of CACNA1G and the identification of other related genes is important to finding the cause of
autism, but much more data and samples are needed in order to accurately study the subject.
Genetic studies involving twins are very useful in revealing the heritability of traits.
Studies have shown autism to have a high heritability; the concordance rate in monozygotic
twins is between 60% and 90%, while it is less than 5%in dizygotic twins (Ronald, 2006). The
study concluded,
“When MZ (monozygotic) twins are more than twice as similar than DZ (dizygotic)
twins, this suggests non-additive genetic influences such as dominance (interaction of
two alleles at the same loci) and epistasis (interaction of alleles at different loci), or
possible contrast effects” (Ronald, 2006).
Once potential gene loci are identified, more specific research on the function of those genes can
take place. Until then, heritability studies such as these continue to narrow the search for a
genetic component of autism.

6

Alex Power
HNR 499

In order to collect more genetic data on autism, an international collaborative project
call the Autism Genome Project (AGP) was developed. The members of the AGP have
published over 200 studies since 2003, and many breakthroughs have been made using the data
collected. One such study conducted a genome-wide scan for alleles associated with autism
risk, and successfully identified at least 5 new candidates (Anney, 2010). Much of the AGP
data is still under analysis, but it will surely produce more significant advancements and
discoveries in the future.
The development of the autistic brain is a very interesting subject, with many novel
research ideas stemming from it. A unique 2010 study assessed moral judgement in adults with
high functioning autism (HFA) and Asperger Syndrome. They found that the subjects had
difficulty assessing the severity of a transgression, which may be due to a defect in the
cognitive appraisal system linked to moral reasoning (Zalla, 2011). Investigations such as
these allow us to see the difference between the autistic brain and a “normal” one. Some
differences appear profound, while on some levels, they are indistinguishable.
The Wakefield Study and Other Media Controversy
In 1998, the medical journal The Lancet published Dr. Andrew Wakefield’s study
suggesting a link between the commonly administered measles, mumps, and rubella (MMR)
vaccination, and autism (WAKEFIELD, 1998). Although his findings were eventually
debunked and he was banned from practicing medicine in 2010, the consequences of his
fraudulent research still echo today. Dr. Wakefield proposed that the trivalent MMR
vaccination, usually given between 1 and 4 years of age (the same time frame that symptoms
of ASD become apparent), overwhelmed the immune system leading to a condition he called
“Autistic enterocolitis”. While this was a valid hypothesis that could certainly warrant further
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investigation, Wakefield’s methods and motives were so flawed and perverted that no valid
conclusions could be drawn from them. He even admitted to paying children at his son’s
birthday party for blood samples (Dyer, 2007). When Dr. Wakefield’s research was first
exposed to the general public, it ignited a fear of not only the MMR vaccine, but of
vaccinations in general. By 2004, 10 of the 13 other authors on the controversial study had
since removed their affiliations with the findings, and The Lancet published a retraction on the
article, citing it as “unethical” (Hope, 2004). Unfortunately, by the time the study was
retracted, the damage had already been done. Many parents in the U.K and U.S began opting
not to vaccinate their children, with their decisions being supported by sensational media and
ill-informed celebrities such as American actress and anti-vaccination activist Jenny McCarthy.
Vaccination rates in the UK dropped to as low as 61%, far below the WHO recommended 90%
(Murch, 2003). As a result, herd immunity began to lose it’s effect, and children began
contracting illnesses such as Measles and Mumps at a much higher rate across the UK. These
illnesses seem almost archaic to the developed world, mainly because vaccination has all but
eradicated them, yet, due to misdirected fear, children were not well protected against them.
Since the public defamation of Dr. Wakefield, the medical research community has
been more cautious on the subject of faulty research, but unfortunately, the media is not so
scrupulous. In 2011, a research study reviewing the current body of autism research presented
a theory for the pathogenesis of autism that proposed residual human DNA from the fetal cells
used in production of the chickenpox vaccine led to inflammation of the brain and thus autism
(Ratajczak, 2011). This theory, while only supported by one citation of a personal
communication, see (Ratajczak, 2011), was only proposed as such in the study. However,
when CBS news reported on the study (Attkisson, 2011) fear of vaccines surged again in the
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US. Even if it was unintentional, widespread fear of safe vaccinations is not a desirable
outcome of any news report.
These controversies have shown the significant impact that the media is capable of
producing, practically overnight. The media has the ability to steer public opinion and thus has
an extremely strong influence in the direction of research. The power of sensationalizing
science led to the the now infamous Wakefield study. When parents opt to not vaccinate their
children, they are often not making an informed decision for their child’s beneficence, as the
illnesses immunizations are proven to prevent are more damaging than the potential side
effects in almost all cases. Furthermore, only a few specific vaccinations, such as the MMR
and Chickenpox vaccine, have even had a suspected risk for autism, but parents often ignore
jabs altogether hoping to protect their children. In order to help educate families of autistic
children, the american non-profit ASAT (Association in Science for Autism Treatment) was
formed. Since its establishment in 1998, ASAT has been providing education to families and
parents in order to prevent the use of “fad” treatments without scientific support, and has
advocated against sensationalized media claims. Fear is a powerful motivator, and the media
has a responsibility to make clear distinctions between theory and fact in order to both fulfill
their obligations as a news outlet and to prevent misguided panic.
Treatment:
Even though the cause of ASD is still unidentified, it is still essential to investigate
possible treatments for the condition. Because the physiologic mechanisms of autism are
unclear, this is a very difficult task. There are still, however, a number of investigational
approaches to treatment available. Currently, the most effective and used treatment for autism
is behavioral therapy (CDC website, 2010). Many methods exist, but most of them focus on
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teaching specific skills using reinforcement. These methods aim to asses the difficulties
children with autism have, including verbal behavior and communication, social interactions,
motor skills, and integration with groups. These behavioral therapies are also highly
modifiable to accommodate for the variable spectrum of severities and diversity of symptoms
among autistic individuals. The National Institute for Mental Health (NIMH) recommends that
behavioral therapy start as soon as diagnosis. For these non-drug treatment options to be
maximally effective, they must be carefully tailored and constantly modified on an individual
basis. This often means an entire team of health care specialists become involved, which can
create stress for the parents and families of children with ASD. Parents of autistic children
often struggle coordinating appointments, tests and assessments, as well as normal education,
in a balance most beneficial for their child.
. It is estimated that the average lifetime cost of care for an individual with autism is
$3.2 million (Rubenstein, 2006). This translates to an approximate expenditure of $35 billion
per year for all of those with autism in the US. Given the economic stress that the current
trending increase in the prevalence of autism is creating, the government has taken an
increased interest in ASD research and epidemiology. A massive surveillance project, called
ADDM (Autism and Developmental Disabilities Monitoring network) was initiated in 2000 by
the CDC. The ADDM network has since expanded to 14 monitoring sites across the country,
including a data coordinating center at Michigan State University. This is the network that
compiles the data for the literature accepted national statistics on autism prevalence. Increased
funding would allow more data collection sites and more accurate data. Aside from
government programs, many non-profit agencies, medical systems, and interest groups
contribute as well. An example of a more local organization striving to do so is the Michigan
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Institute for Neurological Disorders, or MIND. Organizations like MIND help patients and
parents of patients to create a network of therapists and physicians that are working together to
individually cater to each patient.
Behavioral therapy, while it is the best available treatment, is not the only option
available for ASD. Some of the symptoms associated with autism can include violence,
aggression, excessive energy, and self mutilation. For this reason, ADHD drugs,
antidepressants, antipsychotics, and seizure medications are used, often in combination, to
alleviate these symptoms. It is important to note that none of these address the root cause of
autism, and are only used in an off-label fashion to treat symptoms. The use of these drugs can
complicate or benefit therapy due to the behavior modification they can cause, and it is ideal to
keep their use to a minimum, since the neurophysiology of autism is not well understood.
There are also dietary treatments such as gluten free diets in use by many parents, and
supported by high profile social figures, to manage autism, while there is little scientific
evidence to support these methods (Alpert, 2007).
Autism is often thought of as a childhood disease, and not much emphasis is placed on
treating adults with ASD. This assumption is not accurate since autism is a
neurodevelopmental disorder that, while it may change in presentation, is usually a life-long
condition. It is important to address the different needs of adults with ASD so that they can
receive effective treatment. Public schools will provide education for persons with ASD until
the age of 22 (NIMH), but after that age, options are limited depending on the severity of the
condition. Individuals with high functioning autism can often live on their own with minimal
assistance, and government programs can provide financial assistance to those who choose to
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do so. People with more severe disabilities can still thrive in environments such as “skilldevelopment homes” and supervised group living.
Autism, in the current understanding, has no cure, and is a life-long affliction. Because
of this, treatment can be very costly for parents of autistic children. On average, medical
expenses for individuals with ASD are 4.1 to 6.2 times greater than in those without the
condition (CDC, 2012). On top of higher general medical costs, behavioral therapy, which is
essential especially in younger individuals, cost $40,000 to $60,000 a year (CDC, 2012).
Because of the high economic pressure put on families, a streamlined and effective treatment
program should be initiated as early as possible. In order to properly design a treatment
regimen, accurate diagnosis is essential, especially because of the “spectrum” nature of the
disorder.
Conclusions:
The search for the cause of ASD has only recently bloomed in the research community,
and while many projects have been published and others are underway, actual productive
advancements have been slow, but steady. With all of the potential for discovery, the field is
becoming more and more attractive for researchers. ASD research has also become popular
because of the relatively large amount of money available. Since 1997, when the National
Institute of Health created the Autism Coordinating Committee (NIH/ACC), autism research
has had growing support with increasing government funding. Since autism affects so many, it
is one of the few diseases that has strong fundraising through interest groups to finance
research. If this surge of support plays out, an exponential amount of research is on the way.
Collaborations such as the Autism Genome Project as well as other projects in brain mapping
and neuroinformatics show strong potential since there is some emerging evidence that the
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cause of autism may be structurally related on the cellular level. Breakthroughs in other fields,
such as genetics, neuroscience, and embryology all contribute to our understanding of the
autistic syndromes. But where else should researchers look for answers?
Since many of the characteristics affected by autism are uniquely human, animal
models are often not useful. The only source of data in from the affected individuals
themselves, and the ones most in contact with them. More reliable diagnosis will allow for
more effective surveillance and data collection in the upcoming years. With this data, more
accurate estimates of the true prevalence of ASD can be defined, and more cost effective and
practical treatment and assistance programs can be developed. If prevalence is really growing
at the rate CDC data shows, an increasingly significant portion of the population has some type
of ASD, and society must adapt to accommodate. It is important for members of the medical
and research community to stay well informed to avoid unnecessarily repeating studies, and to
help contribute to the general pool of knowledge. Cooperation amongst experts is essential. It
may be years, or it may be decades until the etiology of autism is truly understood, but the
constant progress and dedication from the research community is driving the quest for
understanding.
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